GSKGLAXF
13F holders, Q1 2024 (March 31)2holders
$21.57avg. 13F price*
At the end of Q1 2024, 2 institutions reported holding GSK PLC (GLAXF) in their 13F filings. The largest holders were Aristotle Capital Management, LLC ($73.3M) and Kennedy Capital Management LLC ($3.5M).
- Company
- GSK PLC
- CUSIP
- G3910J179
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
No earlier quarter to compare with.
Ownership 2 holders
| Aristotle Capital Management, LLC | 0.14% | Reduce -0.6% | 3,399,097 | $73.3M |
| Kennedy Capital Management LLC | 0.07% | Add +33.8% | 163,308 | $3.5M |
"% of holder's portfolio" is GLAXF's weight in each manager's 13F, not the share of GSK PLC the manager owns.